TRICIA COLLINS: Open Payments
NPI 1265812879 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,720 in 163 payments from 22 companies in 2025. Trend: 2023 $4,191 · 2024 $4,365 · 2025 $3,720
Food & beverage: $3,386Education: $334
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $486 |
| Janssen Biotech, Inc. | 28 | $478 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 21 | $408 |
| PFIZER INC. | 12 | $323 |
| Novartis Pharmaceuticals Corporation | 19 | $319 |
| Regeneron Healthcare Solutions, Inc. | 11 | $304 |
| UCB, Inc. | 10 | $255 |
| ABBVIE INC. | 11 | $183 |
| Organon LLC | 3 | $144 |
| Arcutis Biotherapeutics, Inc. | 8 | $142 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, CIBINQO, ILUMYA, SKYRIZI, Zoryve.
Industry payments across GA — which companies pay providers there.
